Publications & Works

Articles 49
All (49)
SCI-E, SSCI, AHCI (47)
SCI-E, SSCI, AHCI, ESCI (47)
Scopus (48)
TRDizin (3)
Other Publications (1)
Papers Presented at Peer-Reviewed Scientific Conferences 13

2. MOLNUPIRAVIR: A NEW ANTIVIRAL DRUG FOR COVID-19 TREATMENT

2. INTERNATIONAL MARMARA SCIENTIFIC RESEARCH AND INNOVATION CONGRESS, İstanbul, Turkey, 19 April 2022, pp.63, (Summary Text)

5. Design and Synthesis of Novel 8-Aryl Substituted9-Cyclopentyl Purine Derivatives as PotentialCytotoxic Agents

The 20th International Research Conference, Paris, France, 27 - 28 August 2018, vol.20, pp.2081-2083, (Full Text)

6. NEW PURINE AND PYRIMIDINE NUCLEOSIDE ANALOGS: SYNTHESISAND CYTOTOXIC ACTIVITY ON SELECTED HUMAN CANCER CELL LINES

12th International Symposium onPharmaceutical Sciences (ISOPS-12), Ankara, Turkey, 26 - 29 June 2018, pp.91-92, (Full Text) Sustainable Development

8. SYNTHESIS AND CYTOTOXIC ACTIVITY OF NOVEL 6,9-DISUBSTITUTED PURINE ANALOGS

2nd International Gazi Pharma Symposium Series (GPSS-2017), 11 - 13 October 2017, (Summary Text)

9. Synthesis and In Vitro Anticancer Activity of Novel 6,8,9-Trisubstituted Purine Analogs

3 rd International Multidisciplinary Symposium on Drug Research and Development - DRD 2017, Erzurum, Turkey, 5 - 07 October 2017, (Summary Text)

10. Synthesis and Cytotoxic Activities of New Nucleobase andNucleoside analogs

VEK 3rd International Convention ofPharmaceuticals and Pharmacies, İstanbul, Turkey, 26 - 29 April 2017, (Summary Text)

11. A QSAR Study On Cytotoxic Activities Of Novel 6,8,9 -Trisubstituted Purine Derivatives

21st European Symposium on Quantitative Structure-Activity Relationship, Verona, Italy, 4 - 08 September 2016, (Full Text)
Metrics

Publication

67

Publication (WoS)

47

Publication (Scopus)

48

Citation (WoS)

708

H-Index (WoS)

17

Project

7

Thesis Advisory

5

Open Access

7
UN Sustainable Development Goals